Inhibition of reactive oxygen species downregulates the MAPK pathway in rat spinal cord after limb ischemia reperfusion injury

International Journal of Surgery

Volumn 22, Issue , 2015, Pages 74-78

  Choi, Eun Kyung ^a   Yeo, Jin Seok ^a   Park, Chan Yoon ^a   Na, Ho in ^a   Lim, Jung a ^a   Lee, Jeong Eun ^a   Hong, Seong Wook ^a   Park, Sung Sik ^a   Lim, Dong Gun ^a   Kwak, Kyung Hwa ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Ischemia reperfusion injury; MAPK; Reactive oxygen species

Indexed keywords

5,10,15,20 TETRAKIS (N METHYL 4' PYRIDYL) PORPHYRINATO IRON (III); ALLOPURINOL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PEROXYNITRITE; PROTEIN SERINE THREONINE KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; HINDLIMB; INTRACELLULAR SIGNALING; LIMB INJURY; LIMB ISCHEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SPINAL CORD; ANIMAL; DOWN REGULATION; METABOLISM; RANDOMIZATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SPINAL CORD;

EID: 84943523203     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2015.08.016     Document Type: Article

References (40)

1. Wang W.Z., Baynosa R.C., Zamboni W.A. Therapeutic interventions against reperfusion injury in skeletal muscle. J. Surg. Res. 2011, 171:175-182.
2. Hess M.L., Manson N.H. Molecular oxygen: friend and foe. the role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J. Mol. Cell Cardiol. 1984, 16:969-985.
3. Lefer A.M., Weyrich A.S., Buerke M. Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc. Res. 1994, 28:289-294.
4. Son Y., Cheong Y.K., Kim N.H., Chung H.T., Kang D.G., Pae H.O. Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?. J. Signal Transduct. 2011, 2011:792639.
5. Winter-Vann A.M., Johnson G.L. Integrated activation of MAP3Ks balances cell fate in response to stress. J. Cell Biochem. 2007, 102:848-858.
6. Lan A., Liao X., Mo L., et al. Hydrogen sulfide protects against chemical hypoxia-induced injury by inhibiting ROS-activated ERK1/2 and p38MAPK signaling pathways in PC12 cells. PLoS One 2011, 6:e25921.
7. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331.
8. Safirstein R., DiMari J., Megyesi J., Price P. Mechanisms of renal repair and survival following acute injury. Semin. Nephrol. 1998, 18:519-522.
9. Nagata Y., Todokoro K. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 1999, 94:853-863.
10. Emrecan B., Tulukoglu E., Bozok S., et al. Effects of iloprost and pentoxifylline on renal ischemia-reperfusion in rabbit model. Eur. J. Med. Res. 2006, 11:295-299.
11. Gradl G., Gaida S., Finke B., et al. Supernatant of traumatized muscle induces inflammation and pain, but not microcirculatory perfusion failure and apoptotic cell death. Shock 2005, 24:219-225.
12. Yasa H., Yakut N., Emrecan B., et al. Protective effects of levosimendan and iloprost on lung injury induced by limb ischemia-reperfusion: a rabbit model. J. Surg. Res. 2008, 147:138-142.
13. Olguner C., Koca U., Kar A., et al. Ischemic preconditioning attenuates the lipid peroxidation and remote lung injury in the rat model of unilateral lower limb ischemia reperfusion. Acta Anaesthesiol. Scand. 2006, 50:150-155.
14. Fischer S., Wiesnet M., Renz D., Schaper W. H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur. J. Cell Biol. 2005, 84:687-697.
15. Przyklenk K., Darling C.E., Dickson E.W., Whittaker P. Cardioprotection 'outside the box'-the evolving paradigm of remote preconditioning. Basic Res. Cardiol. 2003, 98:149-157.
16. Kwak K.H., Han C.G., Lee S.H., et al. Reactive oxygen species in rats with chronic post-ischemia pain. Acta Anaesthesiol. Scand. 2009, 53:648-656.
17. Kwak K.H., Jung H., Park J.M., et al. A peroxynitrite decomposition catalyst prevents mechanical allodynia and NMDA receptor activation in the hind-paw ischemia reperfusion injury rats. Exp. Ther. Med. 2014, 7:508-512.
18. Fowkes F.G., Anandan C.L., Lee A.J., et al. Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease. J. Vasc. Surg. 2006, 43:474-480.
19. Yassin M.M., Harkin D.W., Barros D'Sa A.A., Halliday M.I., Rowlands B.J. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J. Surg. 2002, 26:115-121.
20. Mansour Z., Charles A.L., Kindo M., et al. Remote effects of lower limb ischemia-reperfusion: impaired lung, unchanged liver, and stimulated kidney oxidative capacities. Biomed. Res. Int. 2014, 2014:392390.
21. Miller C.C., Villa M.A., Achouh P., et al. Intraoperative skeletal muscle ischemia contributes to risk of renal dysfunction following thoracoabdominal aortic repair. Eur. J. Cardiothorac. Surg. 2008, 33:691-694.
22. Takhtfooladi M.A., Takhtfooladi H.A., Moayer F., Karimi P., Asl H.A. Effect of otostegia persica extraction on renal injury induced by hindlimb ischemia-reperfusion: a rat model. Int. J. Surg. 2015, 13:124-130.
23. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
24. Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279:L1005-L1028.
25. Aikawa R., Komuro I., Yamazaki T., et al. Oxidative stress activates extracellular signal-regulated kinases through src and ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 1997, 100:1813-1821.
26. Haagenson K.K., Wu G.S. The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment. Cancer Metastasis Rev. 2010, 29:143-149.
27. Torres M., Forman H.J. Redox signaling and the MAP kinase pathways. Biofactors 2003, 17:287-296.
28. Norcini M., Vivoli E., Galeotti N., Bianchi E., Bartolini A., Ghelardini C. Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. Pain 2009, 146:141-147.
29. Stambe C., Atkins R.C., Hill P.A., Nikolic-Paterson D.J. Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis. Kidney Int. 2003, 64:2121-2132.
30. Han C.G., Han J.K., Park K.B., Kwak K.H., Park S.S., Lim D.G. Effect of superoxide on the development and maintenance of mechanical allodynia in a rat model of chronic post-ischemia pain. Korean J. Anesthesiol. 2012, 63:149-156.
31. Jin S.X., Zhuang Z.Y., Woolf C.J., Ji R.R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 2003, 23:4017-4022.
32. Zhuang Z.Y., Gerner P., Woolf C.J., Ji R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 114:149-159.
33. Wang J., Shen Y.H., Utama B., et al. HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis- involvement of ERK pathway. FEBS Lett. 2006, 580:2779-2787.
34. Lee J.S., Kim S.Y., Kwon C.H., Kim Y.K. EGFR-dependent ERK activation triggers hydrogen peroxide-induced apoptosis in OK renal epithelial cells. Arch. Toxicol. 2006, 80:337-346.
35. Dong J., Ramachandiran S., Tikoo K., Jia Z., Lau S.S., Monks T.J. EGFR-independent activation of p38 MAPK and EGFR-dependent activation of ERK1/2 are required for ROS-induced renal cell death. Am. J. Physiol. Ren. Physiol. 2004, 287:F1049-F1058.
36. Sanada S., Kitakaze M., Papst P.J., et al. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ. Res. 2001, 88:175-180.
37. Nakano A., Cohen M.V., Critz S., Downey J.M. SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts. Basic Res. Cardiol. 2000, 95:466-471.
38. Chen Y., Zhou J., Li J., Yang S.B., Mo L.Q., Hu J.H., Yuan W.L. Electroacupuncture pretreatment prevents cognitive impairment induced by limb ischemia-reperfusion via inhibition of microglial activation and attenuation of oxidative stress in rats. Brain Res. 2012, 1432:36-45.
39. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 2010, 1802(4):396-405.
40. Meldrum D.R. Tumor necrosis factor in the heart. Am. J. Physiol. 1998, 274:577-595.